FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutics. Described pharmaceutical composition of prolonged release for treating of cerebrovascular disorders. Above composition is made in the form of solid gelatine capsules and/or tablets. As an active substance contains 1-hydroxy-4-adamantanone. As an excipients are used fillers, prolonging polymers, sliding substance in amount of (wt%): 1-hydroxy-4-adamantanone – 5.0–50.0; filler – 2.0–92.5; prolonging polymer – 2.0–55.5; lubricant – 0.5–15.0.
EFFECT: invention provides increasing of efficiency of using said active substance.
4 cl, 23 ex, 6 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
| PROLONGED PHARMACEUTICAL COMPOSITION DRUG FORM AND METHOD OF ITS PRODUCTION (VERSIONS) | 2009 |
|
RU2435584C2 |
| PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE WITH ANTIPSYCHOTIC ACTIVITY AND SYNTHESIS METHODS THEREOF | 2012 |
|
RU2584653C2 |
| DRUG BASED ON TETRAMETILTETRAAZOBITSIKLOOKTANDION AND METHOD FOR ITS PRODUCTION | 2012 |
|
RU2611194C2 |
| PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
| PROLONGED ACTION PHARMACEUTICAL COMPOSITION BASED ON 5-ETHOXY-2-[2-(MORPHOLINO)-ETHYLTHIO]BENZIMIDAZOLE DIHYDROCHLORIDE AND/OR BASE (APHOBAZOLUM) | 2017 |
|
RU2694837C2 |
| PHARMACEUTICAL COMPOSITION WITH ANTI-ISCHEMIC AND ANTIOXIDANT ACTIVITY AND METHOD FOR PREPARING IT | 2013 |
|
RU2545833C1 |
| MODIFIED RELEASE DOSAGE FORM OF TRIMETAZIDINE DIHYDROCHLORIDE | 2009 |
|
RU2412706C1 |
| PHARMACEUTICAL ANTI-DIABETIC COMPOSITION BASED ON SUBSTITUTED THIOPHENE CARBOXYLATE AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2688235C1 |
| PHARMACEUTICAL COMPOSITION OF IMATINIB OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD FOR PREPARING IT AND METHOD(S) OF TREATING | 2012 |
|
RU2517216C2 |
